Inpatient and Outpatient Orderable

CSF Encephalopathy, Autoimmune/Paraneoplastic Evaluation

Synonyms

ENC1
ENCEPHALOPATHY EVAL,CSF
LAB11489

Cerner Name

Clinical Info

Evaluating new onset encephalopathy (noninfectious or metabolic) comprising confusional states, psychosis, delirium, memory loss, hallucinations, movement disorders, sensory or motor complaints, seizures, dyssomnias, ataxias, nausea, vomiting, inappropriate antidiuresis, coma, dysautonomias, or hypoventilation in spinal fluid specimens

Specimen Sources

Lumbar Puncture

Specimen Types

Cerebrospinal Fluid

Container

Sterile

Collection Instructions

Container/Tube: Sterile Vial
Specimen: 4 mL CSF (2 mL min)
This test is intended to be ordered for adult patients. If this test is ordered for a patient younger than 18 years of age,
it will be canceled and automatically reordered by the laboratory as PCDEC / Pediatric Autoimmune
Encephalopathy/CNS Disorder Evaluation, Spinal Fluid.

Specimen Volume

4 mL CSF (2 mL min)

Transport Instructions

72 Hours Room Temperature

Specimen Stability

3 Days Room Temperature
28 Days Refrigerated
28 Days Frozen

Methodology

Indirect Immunofluorescence Assay (IFA)
Cell-Binding Assay (CBA)
Western Blot (WB)
Immunoblot (IB)
Radioimmunoassay (RIA)

Days Performed

TAT: 9 - 13 Days

Performing Laboratory

Mayo Medical Laboratories

CPT

86255 x 23
86341
LOINC Code: 94708-5

PDM

1759170

Only Orderable at Locations:

Orderable Everywhere

Results

Component Name	Base Name	Common Name	External Name
ENCEPHALOPATHY, INTERPRETATION, CSF	ENCEPHINTCSF	ENCEPHALOPATHY, INTERPRETATION, CSF	Encephalopathy, Interpretation, CSF
IFA NOTES	IFANOTES	IFA NOTES	IFA Notes
AMPA-R AB CBA, CSF	AMPARABCBA	AMPA R AB CBA, CSF	AMPA-R Ab CBA, CSF
AMPHIPHYSIN AB, CSF	AMPHIPHYABC	AMPHIPHYSIN AB, CSF	Amphiphysin Ab, CSF
ANTI-GLIAL NUCLEAR AB, TYPE 1	GLIALNUCAB1	ANTI GLIAL NUCLEAR AB, TYPE 1	AGNA-1, CSF
ANTI-NEURONAL NUCLEAR AB, TYPE 1	ANNAB1	ANTI NEURONAL NUCLEAR AB, TYPE 1	ANNA-1, CSF
ANTI-NEURONAL NUCLEAR AB, TYPE 2	ANNAB2	ANTI NEURONAL NUCLEAR AB, TYPE 2	ANNA-2, CSF
ANTI-NEURONAL NUCLEAR AB, TYPE 3	ANNAB3	ANTI NEURONAL NUCLEAR AB, TYPE 3	ANNA-3, CSF
CASPR2-IGG CBA, CSF	CASPR2	CASPR2 IGG CBA, CSF	CASPR2-IgG CBA, CSF
CRMP-5-IGG, CSF	CRMP5IGGCSF	CRMP 5 IGG, CSF	CRMP-5-IgG, CSF
GABA-B-R AB CBA, CSF	GABABRCSF	GABA B R AB CBA, CSF	GABA-B-R Ab CBA, CSF
GAD65 AB ASSAY, CSF	GAD65	GAD65 AB ASSAY, CSF	GAD65 Ab Assay, CSF
GFAP IFA, CSF	GFAP	GFAP IFA, CSF	GFAP IFA Titer, CSF
MGLUR1 AB IFA, CSF	MGLUR1	MGLUR1 AB IFA, CSF	mGluR1 Ab IFA, CSF
LGI1-IGG CBA, CSF	LG1IGGCSF	LGI1 IGG CBA, CSF	LGI1-IgG CBA, CSF
NIF IFA, CSF	NIFIFA	NIF IFA, CSF	NIF IFA, CSF
NMDA-R AB CBA, CSF	NMDARABCBA	NMDA R AB CBA, CSF	NMDA-R Ab CBA, CSF
PURKINJE CELL CYTOPLASMIC AB TYPE 1	PURCYTO1	PURKINJE CELL CYTOPLASMIC AB TYPE 1	PCA-1, CSF
PURKINJE CELL CYTOPLASMIC AB TYPE 2	PURCYTO2	PURKINJE CELL CYTOPLASMIC AB TYPE 2	PCA-2, CSF
PURKINJE CELL CYTOPLASMIC AB TYPE TR	PURCYTOTR	PURKINJE CELL CYTOPLASMIC AB TYPE TR	PCA-Tr, CSF
DPPX AB IFA, CSF	DPPXABIFACSF	DPPX AB IFA, CSF	DPPX Ab IFA, CSF
IGLON5 IFA, CSF	IGLON5IFA	IGLON5 IFA, CSF	IgLON5 IFA, CSF

Result Interpretation

See Report

Forms

LAB11489

Search: .supercomplete-item { width: 600px; white-space: nowrap; overflow: hidden; text-overflow: ellipsis; } $(document).ready(function() { $("#search_input").supercomplete(); });